Investigating the role of WNT signaling in cartilage health and osteoarthritis
WNT signaling in chondrocyte biology and osteoarthritis
This study is looking at how a specific signaling process affects the cartilage cells in your hips, especially for people dealing with hip osteoarthritis, to find ways to improve cartilage health and possibly create new treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10808343 on NIH RePORTER |
What this research studies
This research focuses on understanding how WNT signaling affects chondrocytes, the cells responsible for cartilage health, particularly in the context of hip osteoarthritis (OA). By comparing cartilage from patients with femoroacetabular impingement (FAI) and OA, the researchers aim to uncover the mechanisms that regulate WNT16 expression, which is linked to the severity of OA. The study will utilize advanced techniques like RNA sequencing and mechanical loading experiments to explore how these signaling pathways can be manipulated to improve cartilage function and potentially develop new therapies for OA.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hip osteoarthritis or symptomatic femoroacetabular impingement.
Not a fit: Patients with osteoarthritis not affecting the hip or those without symptomatic femoroacetabular impingement may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow down or reverse the progression of hip osteoarthritis, improving quality of life for patients.
How similar studies have performed: Previous research has shown promising results in understanding the role of WNT signaling in cartilage biology, suggesting that this approach could yield valuable insights.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Wu, Chia-Lung — University of Rochester
- Study coordinator: Wu, Chia-Lung
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.